Paulo Carvalho
About Paulo Carvalho
Paulo Carvalho is the Founder and Chief Operating Officer at Strategikon Pharma, managing the software development team and bringing extensive experience in decision systems engineering, financial markets, and pharmaceutical FP&A services.
Paulo Carvalho Founder and Chief Operating Officer
Paulo Carvalho is the founder and Chief Operating Officer at Strategikon Pharma. In his role, he oversees the software development team, guiding the creation and implementation of innovative solutions tailored for the pharmaceutical industry. His leadership drives the technical direction of the company, ensuring that the software development aligns with the strategic goals of Strategikon Pharma.
Paulo Carvalho Education and Expertise
Paulo Carvalho possesses a robust educational background and diverse expertise. He received a BSc in Decision Systems Engineering from the Management and Technology Institute (COCITE) in Lisbon, Portugal. He later pursued an MBA from the Portuguese Catholic University (UCP) in Lisbon, broadening his managerial and business skills. Additionally, he earned an MSc in Finance from the University of Wisconsin Madison, equipping him with advanced financial knowledge and analytical skills.
Paulo Carvalho Background in Financial Markets and Trading
Paulo Carvalho has significant experience in financial markets and trading. His background includes working in financial markets, where he honed his skills in trading and financial analysis. This experience has provided him with critical insights into financial operations and market dynamics.
Paulo Carvalho at Hovione (Americas)
Paulo Carvalho managed the Cost Proposal and oversaw business operational functions at Hovione (Americas). His role involved handling significant operational responsibilities and ensuring the effective management of proposals and business activities within the company.
Paulo Carvalho FP&A Services in the Pharmaceutical Industry
Paulo Carvalho has provided Financial Planning & Analysis (FP&A) services for top Bay Area pharmaceutical companies. His notable clients included Gilead, Achaogen, and Medivation (now part of Pfizer). Through his expertise, he contributed to the financial planning, budgeting, and analytical strategies of these significant pharmaceutical entities.